ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS)

$0.03879 -0.00221 (-5.3902%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 73

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) News Sources

Sapu Nano Unveils Progress in Deciparticle™ Nanomedicine Platform and AI-Driven Oncology Development at BIO 2026

28-05-2026

yahoo.com

TechForce Robotics Enters Pharmaceutical Automation Market Through Initial Deployment at Oncotelic Therapeutics

01-06-2026

yahoo.com

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure

02-06-2026

yahoo.com

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

03-06-2026

yahoo.com

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies

04-06-2026

yahoo.com

Oncotelic Showcases PDAOAI™ Capability in Advancing Drug Development. Featured in Qdrant Vector Space Day 2026 Keynote

08-06-2026

yahoo.com

Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services

17-06-2026

yahoo.com

Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026

18-06-2026

yahoo.com

Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003

29-06-2026

yahoo.com

Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway

07-07-2026

yahoo.com

ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) Sentiment Trend

0 25 50 75 100 74 73 72 61 70 80 83 76 69 68 28-05-2026 01-06-2026 02-06-2026 03-06-2026 04-06-2026 08-06-2026 17-06-2026 18-06-2026 29-06-2026 07-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) FAQs

toggle

What is the current price of ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS)?

The current price of ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) is $0.03879.


toggle

ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) absolute price change since previous trading day?

The absolute price change of ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) since the previous trading day is $-0.00221.


toggle

ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) percentage price change since previous trading day?

The percentage price change of ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) since the previous trading day is -5.3902%.


toggle

What is the most recent average sentiment score for ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS)?

The most recent average sentiment score for ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) is 73 out of 100.


toggle

What is the most recent average sentiment for ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS)?

The most recent sentiment for ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS) is .


SEC-8K** Filing Available For ONCOTELIC THERAPEUTICS INC (OTLC:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.